Live from the NIH registry
Studies recruiting near Nashua right now
Top 25 of 269 recruiting studies, sorted by proximity — each links to its official registry page
Neural Correlates of Stress and Perceived Control in Adolescent Depression
Major Depressive Disorder
N/A
Interventional 80 participants sought
McLean Hospital — Belmont, Massachusetts (29.1 mi)
· Sponsor: Mclean Hospital
CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
Atopic Dermatitis
N/A
Observational 1,500 participants sought
CorEvitas, LLC — Waltham, Massachusetts (28.8 mi)
· Sponsor: CorEvitas
Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet
Cystic Fibrosis (CF), Cystic Fibrosis Gastrointestinal Disease
N/A
Interventional 20 participants sought
Dartmouth Health Children's — Manchester, New Hampshire (17.1 mi)
· Sponsor: Dartmouth-Hitchcock Medical Center
A Natural History Study of Angelman Syndrome
Angelman Syndrome, Neurodevelopmental Conditions
N/A
Observational 40 participants sought
MGH Lurie Center for Autism — Lexington, Massachusetts (24.9 mi)
· Sponsor: Massachusetts General Hospital
PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents
Vitiligo
N/A
Observational 2,500 participants sought
CorEvitas, LLC — Waltham, Massachusetts (28.8 mi)
· Sponsor: CorEvitas
A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)
Ovarian Cancer, Peritoneal Cancer
Phase 3
Interventional 646 participants sought
Lahey Clinic ( Site 0042) — Burlington, Massachusetts (22.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Elliot Hospital — Manchester, New Hampshire (17.1 mi)
· Sponsor: SWOG Cancer Research Network
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
Advanced Cancer, Metastatic Cancer
N/A
Interventional 1,000 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (17.1 mi)
· Sponsor: Alliance Foundation Trials, LLC.
Utilizing Battlefield Acupuncture to Treat Chronic Pain
Chronic Pain, Substance Use Disorders
N/A
Interventional 125 participants sought
Bedford VA Healthcare System — Bedford, Massachusetts (20.9 mi)
· Sponsor: Edith Nourse Rogers Memorial Veterans Hospital
Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform
Shwachman-Diamond Syndrome, SDS
N/A
Observational 8,000 participants sought
Shwachman-Diamond Syndrome Alliance Inc. — Woburn, Massachusetts (25.4 mi)
· Sponsor: Shwachman-Diamond Syndrome Alliance Inc
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
MedVadis Research Corporation, LLC — Waltham, Massachusetts (28.8 mi)
· Sponsor: TriGemX Bio, Inc.
Individually Targeted Neuromodulation for Contamination-based OCD
Obsessive-Compulsive Disorder
N/A
Interventional 50 participants sought
McLean Hospital — Belmont, Massachusetts (29.1 mi)
· Sponsor: Mclean Hospital
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (17.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Assessing the Efficacy of an Acceptance-Based Digital Intervention for Veterans With Chronic Pain
Chronic Pain
N/A
Interventional 240 participants sought
VA Bedford HealthCare System, Bedford, MA — Bedford, Massachusetts (20.9 mi)
· Sponsor: VA Office of Research and Development
Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle
Vaginal Dysbiosis
Phase 2
Interventional 30 participants sought
Boston IVF — Waltham, Massachusetts (28.8 mi)
· Sponsor: Freya Biosciences ApS
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Migraine
Phase 3
Interventional 1,800 participants sought
MedVadis Research Corporation, LLC — Waltham, Massachusetts (28.8 mi)
· Sponsor: TriGemX Bio, Inc.
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Elliot Hospital — Manchester, New Hampshire (17.1 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Phase 2
Interventional 310 participants sought
Site 0307 - Lahey Hospital and Medical Center — Burlington, Massachusetts (22.6 mi)
· Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Southern New Hampshire Diabetes and Endocrinology /ID# 257841 — Nashua, New Hampshire (1.6 mi)
· Sponsor: AbbVie
Pharmacologic Augmentation of TMS for Depression With D-serine
Depression
Phase 1
Interventional 60 participants sought
McLean Hospital — Belmont, Massachusetts (29.1 mi)
· Sponsor: Mclean Hospital
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Phase 2, Phase 3
Interventional 590 participants sought
Local Institution - 0600 — Manchester, New Hampshire (17.1 mi)
· Sponsor: Bristol-Myers Squibb
Testing an Adaptive Intervention for Peer-Supported Mobile Health for Primary Care Veterans With Psychological Distress
Psychological Distress
N/A
Interventional 384 participants sought
VA Bedford HealthCare System, Bedford, MA — Bedford, Massachusetts (20.9 mi)
· Sponsor: VA Office of Research and Development
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Phase 3
Interventional 1,514 participants sought
Dana-Farber Cancer Institude at Merrimack Valley — Methuen, Massachusetts (15.3 mi)
· Sponsor: Gilead Sciences
Enhanced Coordinated Specialty Care for Early Psychosis
Psychosis, Schizophrenia
N/A
Interventional 350 participants sought
McLean Hospital OnTrack Clinic — Belmont, Massachusetts (29.1 mi)
· Sponsor: Mclean Hospital
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
MedVadis Research Corporation — Waltham, Massachusetts (28.8 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated